Breakthrough in gene-editing with Cas12a for modeling human diseases

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Simplified Assessment Tool for Psoriatic Arthritis Performs Well

According to a study presented at the American College of Rheumatology (ACR) annual meeting, the newly developed Psoriatic Arthritis 5-Thermometer Scales (PsA-5Ts) is a simple

November 29, 2023

Teva to divest business venture in Japan; Layoffs at Rome Therapeutics

Plus, news about Cyclacel Pharmaceuticals, MediciNova and Revolution Medicines: Teva will divest its Japan business venture to private equity firm: The company Sign up to

December 7, 2024

Apple Watch sales resume after latest twist in Masimo patent case

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Apple smartwatches at the center

January 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.